Progressive Cognitive Improvement in Multiple Sclerosis from Treatment with Electromagnetic Fields

References

• Averbuch-Heller L., Shalev A. Y., Abramowitz M. Z. An unusual presentation of multiple sclerosis. American Journal of Psychiatry 1992; 149: 410–411
   PubMed Web of Science ®Google Scholar
• Baumgarten H. G., Lachenmayer L. Anatomical features and physiological properties of central serotonin neurons. Pharmacopsychiatrie 1985; 18: 180–187
   PubMed Web of Science ®Google Scholar
• Baumgarten H. G., Lachenmayer L., Bjorklund A. Chemical lesioning of indoleamine pathways. Methods in psychohiology, R. D. Myers. Academic Press, New York 1977; vol. 3: 47–98
   Google Scholar
• Bawin S. M., Adey W. R. Sensitivity of calcium binding in cerebral tissue to weak environmental electric fields oscillating at low frequency. Proceedings of the National Academy of Sciences, USA 1976; 73: 1999–2003
   PubMed Web of Science ®Google Scholar
• Beardsley J. V., Puletti F. Personality (MMPI) and cognitive (WAIS) changes after levodopa treatment. Archives of Neurology 1971; 25: 145–150
   PubMedGoogle Scholar
• Beany P. A., Gange J. J. Neuropsychological aspects of multiple sclerosis. Journal of Nervous and Mental Disease 1977; 164: 42–50
   PubMedGoogle Scholar
• Beatty W. W., Goodkin D. E., Beatty P. A., Monson N. Frontal lobe dysfunction and memory impairment in patients with chronic progressive multiple sclerosis. Brain and Cognition 1989; 11: 73–86
   PubMed Web of Science ®Google Scholar
• Bergin J. D. Rapidly progressing dementia in disseminated sclerosis. Journal of Neurology Neurosurgery and Psychiatry 1957; 20: 285–292
   PubMed Web of Science ®Google Scholar
• Blackman C. F. Stimulation of brain tissue in vitro by extremely low frequency, low intensity, sinusoidal electromagnetic fields. Electromagnetic fields and neurobehavioral function, M. E. O'Connor, R. H. Lovely. Alan R. Liss, New York 1988
   Google Scholar
• Brooks D. N., Leenders K. L., Head G., Marshall J., Legg N. J., Jones T. Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry 1984; 47: 1182–1191
   PubMed Web of Science ®Google Scholar
• Brozoski T. J., Brown R. M., Rosvold H. E., Goldman P. S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979; 205: 929–932
   PubMed Web of Science ®Google Scholar
• Caine E. D., Bamford H. A., Schiffer R. B., Shoulson I., Levy S. A controlled neuropsychological comparison of Huntington's disease and multiple sclerosis. Archives of Neurology 1986; 43: 249–254
   PubMed Web of Science ®Google Scholar
• Carroll M., Gates R., Roldan F. Memory impairment in multiple sclerosis. Neuropsychologia 1984; 22: 297–302
   PubMed Web of Science ®Google Scholar
• Charcot J. M. Lectures on the diseases of the nervous system delivered at la salpetriere, G. Sigerson. The New Sydenham Society, London 1877; 194–195
   Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Comings D. E. Tourette syndrome and human behavior. Hope Press, Duarte, CA 1990; 341–361
   Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates C. M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Descarries L., Beaudet A., Watkins K. C. Serotonin nerve terminal in adult rat neocortex. Brain Research 1975; 100: 563–588
   PubMed Web of Science ®Google Scholar
• Diers W. C., Brown C. C. Psychometric patterns associated with multiple sclerosis. Archives of Neurology and Psychiatiy 1950; 63: 760–765
   PubMedGoogle Scholar
• Filley C. M., Heaton R. K., Nelson L. M., Burks J. S., Franklin G. M. A comparison of dementia in Alzheimer's disease and multiple sclerosis. Archives of Neurology 1989; 46: 157–161
   PubMedGoogle Scholar
• Franklin G. M., Nelson L. M., Filley C. M., Heaton R. K. Cognitive loss in multiple sclerosis. Case reports and review of the literature. Archives of Neurology 1989; 46: 162–167
   PubMed Web of Science ®Google Scholar
• Freedman M., Leach L., Kaplan E., Winocur G., Shulman K. I., Delis D. C. Clock drawing: a neuropsychological analysis. Oxford University Press, New York 1994; 6–7
   Google Scholar
• Goldstein G., Shelly C. H. Neuropsychological diagnosis of multiple sclerosis in a neu-ropsychiatric setting. Journal of Nervous and Mental Disease 1974; 158: 280–290
   PubMed Web of Science ®Google Scholar
• Grant I., McDonald W. I., Trimble M. R., Smith E., Reed R. Deficient learning and memory in early and middle phases of multiple sclerosis. Journal of Neurology Neurosurgeiy and Psychiatry 1984; 47: 250–255
   PubMed Web of Science ®Google Scholar
• Heaton R. K., Nelson L. M., Thompson D. S. Neuropsychological findings in relapsing remitting and chronic progressive multiple sclerosis. Journal of Consulting Clinical Psychology 1985; 53: 103–110
   PubMed Web of Science ®Google Scholar
• Huber S. J., Paulson G. W., Shuttleworth E. C. Magnetic resonance imaging correlates of dementia in multiple sclerosis. Archives of Neurology 1987; 44: 732–736
   PubMed Web of Science ®Google Scholar
• Hunt J. R. Multiple sclerosis with dementia. A contribution to the combination form of multiple sclerosis and dementia paralytica. American Journal of Mental Science 1903; 26: 974–985
   Google Scholar
• Ivnik R. J. Neuropsychological test performance as a function of the duration of MS-related symptomatology. Journal of Clinical Psychiatry 1978; 39: 304–312
   PubMed Web of Science ®Google Scholar
• Jaffe R. A., Laszewski B. L., Carr D. B., Phillips R. D. Chronic exposure to a 60-Hz electric field: effects on synaptic transmission and peripheral nerve function in the rat. Bioelectomagnetics 1980; 1: 131–147
   PubMedGoogle Scholar
• Jambor K. L. Cognitive functioning in multiple sclerosis. British Journal of Psychiatry 1969; 115: 765–775
   PubMed Web of Science ®Google Scholar
• Javoy-Agid F., Agid Y. Is the mesocortical dopaminergic system involved in Parkinson's disease?. Neurology 1980; 30: 1326–1330
   PubMed Web of Science ®Google Scholar
• Jennekens-Schinkel A., Sanders E. A. C. M. Decline of cognition in multiple sclerosis: dissociable deficits. Journal of Neurology Neurosurgery and Psychiatry 1986; 49: 1354–1360
   PubMed Web of Science ®Google Scholar
• Johansson B., Roos B. E. 5-hydroxyindoleacetic acid in cerebrospinal fluid of patients with neurological diseases. European Neurology 1974; 11: 37–15
   PubMed Web of Science ®Google Scholar
• Lebrun Y., Hoops R. Intelligence ami aphasia. Swets & Zeitlinger, B. V., Amsterdam 1974
   Google Scholar
• Lezak M. D. Neuropsychological assessmentThird Edition. Oxford University Press, New York 1995; 584–585
   Google Scholar
• Lindvall O., Bjnrklund A., Moore R. Y., Stenevi U. Mesencephalic dopamine neurons projecting to neocortex. Brain Research 1974; 81: 325–331
   PubMed Web of Science ®Google Scholar
• Loranger A. W., Goodell H., McDowell F. H., Lee J. E., Sweet R. D. Intellectual impairment in Parkinson's disease. Brain 1972; 95: 405–412
   PubMed Web of Science ®Google Scholar
• Lyon-Caen O., Jouvet R., Hauser S. Cognitive function in recent onset demyelinating diseases. Archives of Neurology 1986; 43: 1138–1141
   PubMed Web of Science ®Google Scholar
• McEntee W. J., Crook T. H. Serotonin, memory, and the aging brain. Psychopharmacology 1991; 103: 143–149
   PubMed Web of Science ®Google Scholar
• Mendez M. F., Frey W. H. Multiple sclerosis dementia. Neurology 1992; 42: 696
   PubMed Web of Science ®Google Scholar
• Messerli P., Scroti X., Tissot R. Quelques aspects des troubles de la programmation dans le syndrome frontal. Archives Suisse de Neurologic Neurochirurgie et de Psychiatric 1979; 125: 23–35
   PubMedGoogle Scholar
• Miledi R. Transmitter release induced by injection of calcium ions into nerve terminals. Proceedings of the Royal Society of Biological Sciences 1973; 183: 421–428
   PubMed Web of Science ®Google Scholar
• Palerson A., Zangwill O. L. Disorders of visual space perception associated with lesions of the right cerebral hemisphere. Brain 1944; 67: 331–358
   Google Scholar
• Peyser J. M., Rao S. M., LaRocca N. G., Kaplan E. Guidelines for neuropsychological research in multiple sclerosis. Archives of Neurology 1990; 47: 94–97
   PubMed Web of Science ®Google Scholar
• Rao S. M. Neuropsychology of multiple sclerosis: a critical review. Journal of Clinical and Experimental Neuropsychology 1986; 8: 503–542
   PubMed Web of Science ®Google Scholar
• Rao S. M., Hammeke T. A., MeQuillen M. P., Khatri B. O., Lloyd D. Memory disturbance in chronic progressive multiple sclerosis. Arhives of Neurology 1984; 41: 625–631
   PubMed Web of Science ®Google Scholar
• Rao S. M., Glatt S., Hammeke T. A. Chronic progressive multiple sclerosis: relationship between cerebral ventricular size and neuropsychological impairment. Archives of Neurology 1985; 42: 678–682
   PubMed Web of Science ®Google Scholar
• Rao S. M., Leo G. J., Bernardin L., Unvcrzagt F. Cognitive dysfunction in multiple sclerosis: II. Frequency, patterns, and prediction. Neurology 1991; 41: 685–691
   PubMed Web of Science ®Google Scholar
• Rao S. M., Leo G. J., Ellington L., Nauertz T, Bernardin L., Unverzagt F. Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology 1991; 41: 692–696
   PubMed Web of Science ®Google Scholar
• Reading P. J. Frontal Lobe dysfunction in schizophrenia and Parkinson's disease-a meeting point for neurology, psychology and psychiatry: discussion paper. Journal of the Royal Society of Medicine 1991; 84: 349–353
   PubMed Web of Science ®Google Scholar
• Reichardt L. F., Kelly R. B. A molecular description of nerve terminal function. Annual Review of Biochemistry 1983; 52: 871–926
   PubMed Web of Science ®Google Scholar
• Rosen A. D., Lubowsky J. Magnetic fields influence on central nervous system function. Experimental Neurology 1987; 95: 679–687
   PubMed Web of Science ®Google Scholar
• Ross D. M. The mental symptoms in disseminated sclerosis. Review of Neurology and Psychiatry 1917; 13: 361–373
   Google Scholar
• Rusovan A., Kanje M. D600. a Ca−2 antagonists, prevents stimulation of nerve regeneration by magnetic fields. NeuroReport 1992; 3: 813–814
   PubMed Web of Science ®Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R. Demyelination as an epiphenomenon in multiple sclerosis. International Journal of Neuroscience 1993; 72: 141–148
   PubMedGoogle Scholar
• Sandyk R. Rapid normalization of visual evoked potentials by picotesla range magnetic fields in chronic progressive multiple sclerosis. International Journal of Neuroscience 1994; 77: 243–259
   PubMed Web of Science ®Google Scholar
• Sandyk R. Further observations on the effects of external picotesla range magnetic fields on visual memory and visuospatial functions in multiple sclerosis. International Journal of Neuroscience 1994; 77: 203–227
   PubMed Web of Science ®Google Scholar
• Sandyk R. Improvement in word fluency performance in patients with multiple sclerosis by electromagnetic fields. International Journal of Neuroscience 1994; 79: 75–90
   PubMed Web of Science ®Google Scholar
• Sandyk R. Long term beneficial effects of weak electromagnetic fields in multiple sclerosis. International Journal of Neuroscience 1995; 83: 45–57
   PubMed Web of Science ®Google Scholar
• Sandyk R. Effect of weak electromagnetic fields on body image perception in patients with multiple sclerosis. International Journal ofNeuroscience 1996; 86: 79–85
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal ofNeuroscience 1993; 70: 97–105
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience 1993; 70: 255–269
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. Improvement by picotesla magnetic fields of perceptual-motor performance in a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience 1994a; 78: 53–66
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. Multiple sclerosis: Improvement of visuoperceptive functions by picotesla range magnetic fields. International Journal ofNeuroscience 1994; 74: 177–189
   PubMedGoogle Scholar
• Scatton B., Rouquier L., Javoy-Agid F., Agid Y. Dopamine deficiency in the cerebral cortex in Parkinson disease. Neurology 1982; 32: 1039–1040
   PubMed Web of Science ®Google Scholar
• Sirvio J., Riekkinen P., Jakala P., Riekkinen P. J. Experimental studies on the role of serotonin in cognition. Progress in Neurobiology 1994; 43: 363–379
   PubMed Web of Science ®Google Scholar
• Ska B., Nespoulous J. L. Human figure and bicycle drawings by normnal aged subjects and Alzheimer's type patients. Journal of Clinical and Expoerimental Neuropsychology 1987; 9: 261
   Web of Science ®Google Scholar
• Ska B., Desilets H., Nespoulous J. L. Performances visuo-constructive et vieillissement. Psychologica Belgica 1986; 27: 25–42
   Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Tabaddor K., Wolfson L. I., Sharpless N. S. Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders. Neurology 1978; 28: 1249–1253
   PubMed Web of Science ®Google Scholar
• Taylor E. M. The appraisal of children with cerebral deficits. Harvard University Press, Cambridge, Mass 1959
   Google Scholar
• White R. F. Emotional and cognitive correlates of multiple sclerosis. Journal of Neuropsychiatry 1990; 2: 422–428
   PubMedGoogle Scholar
• Young A. C., Saunders J., Ponsford J. R. Mental change as an early feature of multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry 1976; 39: 1008–1013
   PubMed Web of Science ®Google Scholar